In the current study, for the first time, we comprehensively analyzed the expression details and prognostic significances of MYOs and suggested MYO1B, MYO5A, and MYO10 as effective clinical biomarkers and potential medical targets for HNSCC. This evidence concerns the gene GOSR2 and head and neck squamous cell carcinoma.